Fulgent Genetics, Inc. (FLGT)
19.45
-0.45
(-2.26%)
USD |
NASDAQ |
Aug 24, 16:00
19.43
-0.02
(-0.10%)
After-Hours: 20:00
Fulgent Genetics Debt to Equity Ratio : 0.0096 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0096 |
| March 31, 2026 | 0.0097 |
| December 31, 2025 | 0.0072 |
| September 30, 2025 | 0.0071 |
| June 30, 2025 | 0.0071 |
| March 31, 2025 | 0.0073 |
| December 31, 2024 | 0.0081 |
| September 30, 2024 | 0.0087 |
| June 30, 2024 | 0.0118 |
| March 31, 2024 | 0.0115 |
| December 31, 2023 | 0.0131 |
| September 30, 2023 | 0.0147 |
| June 30, 2023 | 0.0175 |
| March 31, 2023 | 0.0309 |
| December 31, 2022 | 0.0325 |
| September 30, 2022 | 0.0305 |
| June 30, 2022 | 0.0313 |
| March 31, 2022 | 0.0225 |
| December 31, 2021 | 0.0246 |
| September 30, 2021 | 0.0276 |
| June 30, 2021 | 0.0254 |
| March 31, 2021 | 0.0199 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.0278 |
| September 30, 2020 | 0.0147 |
| June 30, 2020 | 0.0329 |
| March 31, 2020 | 0.0316 |
| December 31, 2019 | 0.0323 |
| September 30, 2019 | 0.0509 |
| June 30, 2019 | 0.0545 |
| March 31, 2019 | 0.0577 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Quest Diagnostics, Inc. | 0.8493 |
| Labcorp Holdings, Inc. | 0.7861 |
| OPKO Health, Inc. | 0.3362 |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 0.5706 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.089B |
| Total Liabilities (Quarterly) | 93.24M |
| Shareholders Equity (Quarterly) | 1.002B |
| Current Ratio | 6.338 |
| Net Debt Paydown Yield | -0.05% |